Telegram Group & Telegram Channel
Экс-глава Минздрава Самарской области Армен Бенян стал фигурантом уголовного дела о злоупотреблении должностными полномочиями (ч.3 ст.285 УК РФ) и находится под подпиской о невыезде.

Дело связано с закупкой медицинского оборудования для региона по завышенной цене на средства нацпроекта «Здравоохранение». МВД пока не комментирует ситуацию.



group-telegram.com/medpharm/11337
Create:
Last Update:

Экс-глава Минздрава Самарской области Армен Бенян стал фигурантом уголовного дела о злоупотреблении должностными полномочиями (ч.3 ст.285 УК РФ) и находится под подпиской о невыезде.

Дело связано с закупкой медицинского оборудования для региона по завышенной цене на средства нацпроекта «Здравоохранение». МВД пока не комментирует ситуацию.

BY МедФарм




Share with your friend now:
group-telegram.com/medpharm/11337

View MORE
Open in Telegram


Telegram | DID YOU KNOW?

Date: |

"The result is on this photo: fiery 'greetings' to the invaders," the Security Service of Ukraine wrote alongside a photo showing several military vehicles among plumes of black smoke. Continuing its crackdown against entities allegedly involved in a front-running scam using messaging app Telegram, Sebi on Thursday carried out search and seizure operations at the premises of eight entities in multiple locations across the country. On December 23rd, 2020, Pavel Durov posted to his channel that the company would need to start generating revenue. In early 2021, he added that any advertising on the platform would not use user data for targeting, and that it would be focused on “large one-to-many channels.” He pledged that ads would be “non-intrusive” and that most users would simply not notice any change. As a result, the pandemic saw many newcomers to Telegram, including prominent anti-vaccine activists who used the app's hands-off approach to share false information on shots, a study from the Institute for Strategic Dialogue shows. "The argument from Telegram is, 'You should trust us because we tell you that we're trustworthy,'" Maréchal said. "It's really in the eye of the beholder whether that's something you want to buy into."
from ua


Telegram МедФарм
FROM American